Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.
about
mTOR Regulation of Lymphoid Cells in Immunity to PathogensActivation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.Immunometabolism in systemic lupus erythematosus.IL-2, IL-4, IFN-γ or TNF-α enhances BAFF-stimulated cell viability and survival by activating Erk1/2 and S6K1 pathways in neoplastic B-lymphoid cells.Proteomic changes of CD4+/CD25+/forkhead box p3+ regulatory T cells in a 30-day rat model of sepsis survival.
P2860
Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Rapamycin inhibits BAFF-stimul ...... d neoplastic B-lymphoid cells.
@en
type
label
Rapamycin inhibits BAFF-stimul ...... d neoplastic B-lymphoid cells.
@en
prefLabel
Rapamycin inhibits BAFF-stimul ...... d neoplastic B-lymphoid cells.
@en
P2093
P2860
P1476
Rapamycin inhibits BAFF-stimul ...... d neoplastic B-lymphoid cells.
@en
P2093
Beibei Liu
Chunxiao Liu
Jiamin Qin
Qingyu Zeng
Shuangquan Zhang
P2860
P2888
P304
P356
10.1007/S00018-015-1976-1
P50
P577
2015-06-29T00:00:00Z